Adaptimmune Therapeutics

GSK outlines deal to send cell therapies back to Adaptimmune
BioPharma Dive
Tue, 04/11/23 - 11:41 am
GSK
Adaptimmune Therapeutics
cancer
cell therapy
Adaptimmune absorbs TCR² to extend cash runway and broaden T-cell pipeline
Fierce Biotech
Mon, 03/6/23 - 11:11 am
Adaptimmune Therapeutics
TCR2 Therapeutics
M&A
GSK axes Lyell cell therapy, passes programs to Adaptimmune
Fierce Biotech
Tue, 10/25/22 - 11:04 am
GSK
Lyell
cell therapy
Adaptimmune Therapeutics
2 Biotech Companies That Might Be on Pfizer's Radar Right Now
Motley Fool
Thu, 11/4/21 - 10:37 am
Pfizer
M&A
Adaptimmune Therapeutics
Affimed
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
ESMO
oncology
cancer
Gilead Sciences
Bristol Myers Squibb
Zymeworks
Amgen
Adaptimmune Therapeutics
TCR2 Therapeutics
Boehringer Ingelheim
Roche dives further into cancer cell therapy with Adaptimmune deal
Pharmaforum
Tue, 09/7/21 - 10:57 am
Roche
cell therapy
cancer
Adaptimmune Therapeutics